30 Day Trial

Vericel Reports 1Q17 Orthobiologic Revenue

Share:

Vericel posted 1Q17 orthobiologic revenue of US $5.0MM, -43.2% vs. 1Q16.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.